Showing results (1-10 of 114) with videos related to
Sort By:
Pageof 12
Current Opinion in Molecular Therapeutics|October 2, 2010
Gene therapy for Parkinson's disease: from non-human primates to humansMassimo S Fiandaca, Krystof S BankiewiczJournal of Neuroscience Methods|December 23, 2009
Optimized cannula design and placement for convection-enhanced delivery in rat striatumDali Yin, John Forsayeth, Krystof S BankiewiczExpert Review of Neurotherapeutics|November 25, 2010
Gene therapy for Parkinson's disease: where are we now and where are we going?John Forsayeth, Krystof S Bankiewicz, Michael J AminoffToxins|November 10, 2011
The use of convection-enhanced delivery with liposomal toxins in neurooncologyMassimo S Fiandaca, Mitchel S Berger, Krystof S BankiewiczNeuropharmacology|February 16, 2010
Pharmacokinetics and bioactivity of glial cell line-derived factor (GDNF) and neurturin (NTN) infused into the rat brainPiotr Hadaczek, Louisa Johnston, John Forsayeth, et al.Pharmaceuticals (Basel, Switzerland)|November 28, 2013
Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indicationsMassimo S Fiandaca, Krystof S Bankiewicz, Howard J FederoffNeurobiology of Disease|October 25, 2011
Glial-derived neurotrophic factor gene transfer for Parkinson's disease: anterograde distribution of AAV2 vectors in the primate brainAdrian P Kells, John Forsayeth, Krystof S BankiewiczMethods in Molecular Biology (Clifton, N.J.)|November 28, 2015
MRI-Guided Delivery of Viral VectorsErnesto A Salegio, John Bringas, Krystof S BankiewiczJournal of Parkinson'S Disease|May 6, 2026
Clinical GDNF delivery methods for Parkinson's diseaseMatthias Luz, Massimo S Fiandaca, Krystof S BankiewiczMethods in Enzymology|November 17, 2009
Convection-enhanced delivery of liposomes to primate brainMichal T Krauze, John Forsayeth, Dali Yin, et al.Pageof 12